
### [NCIT:C40109](http://purl.obolibrary.org/obo/NCIT_C40109)
**Label:** Fallopian Tube Mucinous Neoplasm

**Subclasses:** [NCIT:C40103](http://purl.obolibrary.org/obo/NCIT_C40103) (Fallopian Tube Mucinous Adenocarcinoma), [NCIT:C40108](http://purl.obolibrary.org/obo/NCIT_C40108) (Borderline Fallopian Tube Mucinous Tumor), 

**Class expressions from DL-Learner:**

- [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) and (not ([NCIT:C37115](http://purl.obolibrary.org/obo/NCIT_C37115) (Serous Adenocarcinoma Cell))) 53.85%
- Thing 52.89%
- [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) 39.20%
- [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) and (not ([NCIT:C39906](http://purl.obolibrary.org/obo/NCIT_C39906) (Seminal Vesicle Adenocarcinoma))) 39.20%
- [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) and (not ([NCIT:C39905](http://purl.obolibrary.org/obo/NCIT_C39905) (Prostate Stromal Proliferation of Uncertain Malignant Potential))) 39.20%
- [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) and (not ([NCIT:C39903](http://purl.obolibrary.org/obo/NCIT_C39903) (Prostate Adenocarcinoma with Focal Neuroendocrine Differentiation))) 39.20%
- [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) and (not ([NCIT:C39902](http://purl.obolibrary.org/obo/NCIT_C39902) (Prostate Basal Cell Carcinoma))) 39.20%
- [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) and (not ([NCIT:C39901](http://purl.obolibrary.org/obo/NCIT_C39901) (Prostatic Duct Urothelial Carcinoma))) 39.20%
- [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) and (not ([NCIT:C39899](http://purl.obolibrary.org/obo/NCIT_C39899) (Secondary Prostate Urothelial Carcinoma))) 39.20%
- [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) and (not ([NCIT:C39897](http://purl.obolibrary.org/obo/NCIT_C39897) (Prostate Ductal Adenocarcinoma, Solid Pattern))) 39.20%
- [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) and (not ([NCIT:C39896](http://purl.obolibrary.org/obo/NCIT_C39896) (Prostate Ductal Adenocarcinoma, Papillary Pattern))) 39.20%
- [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) and (not ([NCIT:C39895](http://purl.obolibrary.org/obo/NCIT_C39895) (Prostate Ductal Adenocarcinoma, Cribriform Pattern))) 39.20%
- [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) and (not ([NCIT:C3989](http://purl.obolibrary.org/obo/NCIT_C3989) (Parathyroid Hyperplasia))) 39.20%
- [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) and (not ([NCIT:C39885](http://purl.obolibrary.org/obo/NCIT_C39885) (Acinar Prostate Adenocarcinoma, Lymphoepithelioma-Like Variant))) 39.20%
- [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) and (not ([NCIT:C39880](http://purl.obolibrary.org/obo/NCIT_C39880) (Acinar Prostate Adenocarcinoma, Atrophic Variant))) 39.20%


